ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. B.医学系部門(医学部)
  2. 10. 学術雑誌掲載論文

Pitavastatin Decreases Tau levels Via the Inactivation of Rho/ROCK

http://hdl.handle.net/10098/4560
http://hdl.handle.net/10098/4560
a8b4d0b8-c9b7-42db-b945-24776496a047
名前 / ファイル ライセンス アクション
neurobiology_of_aging_revised11.pdf neurobiology_of_aging_revised11.pdf (351.9 kB)
figure.pdf figure.pdf (1.6 MB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2011-12-06
タイトル
タイトル Pitavastatin Decreases Tau levels Via the Inactivation of Rho/ROCK
言語
言語 eng
キーワード
主題Scheme Other
主題 Statin
キーワード
主題Scheme Other
主題 Pleiotrophic effects
キーワード
主題Scheme Other
主題 Tau
キーワード
主題Scheme Other
主題 Neuronal cellular model
キーワード
主題Scheme Other
主題 Small G protein
キーワード
主題Scheme Other
主題 Rho/ROCK
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_1843
資源タイプ other
著者 HAMANO, Tadanori

× HAMANO, Tadanori

HAMANO, Tadanori

Search repository
YEN, Shu-Hui

× YEN, Shu-Hui

YEN, Shu-Hui

Search repository
GENDRON, Tania

× GENDRON, Tania

GENDRON, Tania

Search repository
KO, Li-wen

× KO, Li-wen

KO, Li-wen

Search repository
KURIYAMA, Masaru

× KURIYAMA, Masaru

KURIYAMA, Masaru

Search repository
抄録
内容記述タイプ Abstract
内容記述 Epidemiological studies have shown that long-term treatment with statins decreases the risk of developing Alzheimer's disease. Statins have pleiotropic effects by lowering the concentration of isoprenoid intermediates. Although several studies have shown that statins may reduce amyloid beta protein levels, there have been few reports on the interaction between statins and tau. We report here that pitavastatin reduces total and phosphorylated tau levels in a cellular model of tauopathy, and in primary neuronal cultures. The decrease caused by pitavastatin is reversed by the addition of mevalonate, or geranylgeranyl pyrophosphate. The maturation of small G proteins, including RhoA was disrupted by pitavastatin, as was the activity of glycogen synthase kinase 3β (GSK3β), a major tau kinase. Toxin A, inhibitor of glycosylation of small G proteins, and Rho kinase (ROCK) inhibitor decreased phosphorylated tau levels. Rho kinase inhibitor also inactivated glycogen synthase kinase 3β. Although the mechanisms responsible for the reduction in tau protein by pitavastatin require further examination, this report sheds light on possible therapeutic approaches to tauopathy.
書誌情報 Neurobiology of Aging

巻 33, 発行日 2011-11
出版者
出版者 ELSEVIER
ISSN
収録物識別子タイプ ISSN
収録物識別子 1974580
書誌レコードID
識別子タイプ NCID
関連識別子 TD00006164
著者版フラグ
出版タイプ AO
出版タイプResource http://purl.org/coar/version/c_b1a7d7d4d402bcce
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 13:44:48.124915
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3